HealthcannS.A.Status: Entity active
Research and experimental development on biotechnology
KRS: 0000979833 NIP: 8943154198 REGON: 38610759800000
Overview
Registry date
2022-08-04
Share capital
€50,087.55
Activity description
Healthcann is focused on advancing cannabinoids by developing drug delivery systems that enhance the effectiveness and accessibility of cannabinoid-based treatments. The company aims to create state-of-the-art formulations that provide precise dosing and fast, long-lasting relief for various health conditions. Their technology, including AdvanDrop®, addresses challenges associated with oral delivery of cannabinoids to improve patient compliance and outcomes.
Registered address
Ul. Klecińska 123, 54-413 Wrocław, Poland
Website
healthcann.euWebsite active
Email
[email protected]Email address current
Industry
| Name | Code |
|---|---|
Research and experimental development on biotechnologyPrimary | 72.11.Z |
Manufacture of homogenised food preparations and dietetic food | 10.86.Z |
Manufacture of other food products not elsewhere classified | 10.89.Z |
Manufacture of pharmaceutical preparations | 21.20.Z |
Manufacture of perfumes and toilet preparations | 20.42.Z |
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| AI Corelabsp. z o.o. | €59,554.24 | aicorelab.com | |
| Pominnosp. z o.o. | €60,886.65 | pominno.pl | |
| Orphinic ScientificS.A. | €55,133.05 | orphinic.com | |
| Vitagenumsp. z o.o. | €55,468.57 | vitagenum.pl | |
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | €47,042.91 | geneza.eu | |
| Fundacja Nowych Technologii OrganicznychFoundation | €44,386.92 | [email protected] | |
| WPD PharmaceuticalsS.A. | €30,244.72 | wpdpharmaceuticals.pl/contact/wpdsa/ | |
| UrtesteS.A. | €26,461.24 | urteste.com | |
| SANO - Centrum Zindywidualizowanej Medycyny Obliczeniowej - Międzynarodowa Fundacja BadawczaFoundation | €28,852.82 | sano.science/ | |
| Medtransfersp. z o.o. | €20,611.38 | codete.com |
Last updated: 2026-04-23